Regulatory & Documentation
Sponsor (Clinical Trial)
A sponsor is the individual, company, institution, or organization that takes responsibility for the initiation, management, and financing of a clinical trial, including regulatory submissions, IP supply, monitoring, safety reporting, and reporting of results.
Sponsor obligations are defined in 21 CFR 312 (drugs), 21 CFR 812 (devices), ICH E6(R3), and EU CTR 536/2014. Sponsors may delegate operational tasks to a CRO under a transfer-of-obligations agreement, but cannot delegate regulatory accountability.
Pharmaceutical and biotech companies are the most common sponsors; individual investigators sponsoring under their own IND are sponsor-investigators.
Related terms
Contract Research Organization (CRO)
A Contract Research Organization (CRO) is a service organization that contracts with a pharmaceutical, biotech, or medical-device sponsor to perform some or all of the operational activities of a clinical trial, from protocol design through regulatory submission.
Good Clinical Practice (ICH E6(R3))
Good Clinical Practice (GCP), as defined in ICH E6(R3), is the international ethical and scientific quality standard for designing, conducting, recording, and reporting clinical trials involving human participants.
IND Application (Investigational New Drug)
An Investigational New Drug (IND) application is the submission a sponsor files with the FDA to obtain authorization to ship an unapproved drug across state lines and to administer it to humans in a clinical trial.
Investigator-Initiated Trial (IIT)
An Investigator-Initiated Trial (IIT) is a clinical trial in which an academic or independent investigator (rather than a pharmaceutical or device sponsor) serves as the regulatory sponsor, holds the IND, and is responsible for protocol design, conduct, and reporting.
See how Kitsa applies this in your trials
Kitsa's agentic AI compresses protocol development, site selection, and patient pre-screening from months into weeks.
Request a demo